Candid Therapeutics
Candid Therapeutics is a startup headquartered in San Diego, United States, founded in 2024. It has raised at least $206.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Candid Therapeutics has raised at least $206.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Candid Therapeutics sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in San Diego
- Acurion
- Address Insite
- Aervivo
- Algorithmic Objective
- Alida Biosciences
- AmbyTech
- Avenzo Therapeutics
- Capstan Therapeutics
- CARI Health
- ClickUp
- Cloud Water Filter
Related
- Innovation profile of San Diego
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Candid Therapeutics do?
Candid Therapeutics is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Candid Therapeutics raised?
At least $206.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Candid Therapeutics based?
Candid Therapeutics is headquartered in San Diego, United States.
When was Candid Therapeutics founded?
Candid Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.